about
PSA and beyond: alternative prostate cancer biomarkersProteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate ProductsMolecular markers in prostate cancer. Part I: predicting lethality.A robust automated measure of average antibody staining in immunohistochemistry imagesIdentification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.New serum biomarkers for prostate cancer diagnosis.The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.Orexin expression in different prostate histopathologic examinations: Can it be a marker for prostate cancer? A preliminary result.Extracellular vesicles in prostate cancer: new future clinical strategies?Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis.Comments on the article "Biomarkers for prostate cancer" by Eric Schiffer.A novel fluorescent "Turn-Off/Turn-On" system for the detection of acid phosphatase activity.Chitosan-stabilized platinum nanoparticles as effective oxidase mimics for colorimetric detection of acid phosphatase.Synthesis of functionalized fluorescent gold nanoclusters for acid phosphatase sensing.Near-infrared fluorescence probe for the determination of acid phosphatase and imaging of prostate cancer cells.A colorimetric and near-infrared fluorescent probe with high sensitivity and selectivity for acid phosphatase and inhibitor screening.Q57130729Linking fatherhood to prostate cancer risk
P2860
Q26770646-2FEE2FFA-8E64-453A-9174-876185B0B563Q28533986-87D5A627-1987-4286-B230-F76AFD83D97FQ30373669-D9AD2F3B-C434-47F4-BB92-75ADF617FEB4Q33579610-2670BA42-CF62-412E-84F8-3BBC38E3494CQ34417941-875A1B90-F3B6-48C0-A8D4-DBBF09007210Q34939111-E300CF37-A8DA-44F4-ABE4-8D008885E4FAQ35261674-D19A487B-CA8D-45BF-94F7-E49F8FB1EE33Q35993879-681B19E1-76FA-4ABA-ACDA-363834A30737Q37632337-1C35286F-FCF6-48E0-9CF5-81EB9F5A5357Q37974776-B4EEA354-7361-4162-B13C-C3E130300FEAQ43079252-219E3F3F-7A98-4C3A-B386-17FF2C0B5BBEQ44698347-AC9968D1-2061-4119-AE4F-F2414E87A18EQ47929980-8CAF3DCB-FFE7-4D38-9A6C-DD7E900DDA82Q50436795-3B7B0AB0-7069-45A3-BD30-98883AB6945CQ53326420-2140A088-FD04-4F3F-B780-00A35F6788A8Q54373995-1FE53CF2-4007-4A11-9C5F-C26D08453024Q57130729-0181B9E7-0CE8-46B7-86BF-F09B1955867EQ57422879-D46AEF30-6AA9-40C3-A7F4-0D4CEBA954A1
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Biomarkers for prostate cancer.
@en
type
label
Biomarkers for prostate cancer.
@en
prefLabel
Biomarkers for prostate cancer.
@en
P1476
Biomarkers for prostate cancer.
@en
P2093
Eric Schiffer
P2888
P304
P356
10.1007/S00345-007-0203-6
P577
2007-08-10T00:00:00Z